Catechin Attenuates Coronary Heart Disease in a Rat Model by Inhibiting Inflammation

Area of Science:

• Biochemistry
• Cardiovascular Medicine
• Pharmacology

Background:

• Systemic inflammation is a critical factor in the pathophysiology of coronary heart disease (CHD).
• Investigating natural compounds for anti-inflammatory properties in cardiovascular diseases is crucial.

Purpose of the Study:

• To determine if catechin possesses anti-inflammatory functions in a rat model of coronary heart disease (CHD).
• To evaluate the effects of catechin on CHD-related biochemical parameters and inflammatory signaling pathways.

Main Methods:

• A rat model of CHD was established using a high-fat diet and pituitrin injection.
• Biochemical analysis confirmed the CHD model and assessed the impact of catechin on lipid profiles, cardiac enzymes, and inflammatory biomarkers.
• Western blotting or similar techniques were used to analyze the expression of key inflammatory proteins, including NF-κB, FXR, STAT-3, and PKB/Akt.

Main Results:

• Catechin administration significantly improved cardiac function markers (creatine kinase, LDH, cTnT, LVEF, LVIDs) and normalized lipid profiles and blood glucose in CHD rats.
• Catechin effectively inhibited elevated levels of inflammatory biomarkers such as C-reactive protein, Lp-PLA2, IL-6, and TNF-α.
• Catechin activated anti-inflammatory signaling proteins including farnesoid X receptor, STAT-3, and PKB/Akt, while having a contrasting effect on NF-κB.

Conclusions:

• Catechin demonstrates significant anti-inflammatory and cardioprotective effects in a rat model of CHD.
• The therapeutic potential of catechin in CHD is linked to its ability to suppress inflammation and modulate key signaling pathways like STAT-3.
• Catechin represents a promising therapeutic agent for managing coronary heart disease.